These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16159986)

  • 1. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.
    Kiès P; Leclercq C; Bleeker GB; Crocq C; Molhoek SG; Poulain C; van Erven L; Bootsma M; Zeppenfeld K; van der Wall EE; Daubert JC; Schalij MJ; Bax JJ
    Heart; 2006 Apr; 92(4):490-4. PubMed ID: 16159986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.
    Khadjooi K; Foley PW; Chalil S; Anthony J; Smith RE; Frenneaux MP; Leyva F
    Heart; 2008 Jul; 94(7):879-83. PubMed ID: 18208826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.
    Hauck M; Bauer A; Voss F; Katus HA; Becker R
    Clin Res Cardiol; 2009 Mar; 98(3):189-94. PubMed ID: 19034378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.
    Molhoek SG; Bax JJ; Bleeker GB; Boersma E; van Erven L; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Dec; 94(12):1506-9. PubMed ID: 15589005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N; De Diego C; Vaseghi M; Buch E; Cesario DA; Mahajan A; Wiener I; Fonarow GC; Boyle NG; Shivkumar K
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1363-8. PubMed ID: 17976100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.
    Leon AR; Greenberg JM; Kanuru N; Baker CM; Mera FV; Smith AL; Langberg JJ; DeLurgio DB
    J Am Coll Cardiol; 2002 Apr; 39(8):1258-63. PubMed ID: 11955841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
    Buck S; Rienstra M; Maass AH; Nieuwland W; Van Veldhuisen DJ; Van Gelder IC
    Europace; 2008 May; 10(5):558-65. PubMed ID: 18356205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse remodelling of systolic left ventricular contraction pattern by long term cardiac resynchronisation therapy: colour Doppler shows resynchronisation.
    Schuster P; Faerestrand S; Ohm OJ
    Heart; 2004 Dec; 90(12):1411-6. PubMed ID: 15547015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.